Why it was recalled
Subpotent Drug
Product description
Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01
Lot numbers, UPCs & expiration codes
Lot # C111054; Exp. 02/16
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0161-2016
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Sep 24, 2015
- FDA report date
- Nov 4, 2015
- Quantity
- 21,120 HDPE bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Pfizer Inc.
Original FDA data
Every field from FDA enforcement report D-0161-2016, exactly as published.
Show all FDA fields
- City
- New York
- State
- NY
- Status
- Terminated
- Country
- United States
- Event ID
- 72199
- Address
- 235 East 42nd Street
- Code information
- Lot # C111054; Exp. 02/16
- Postal code
- 10017-5703
- Report date
- Nov 4, 2015
- Product type
- Drugs
- Recall number
- D-0161-2016
- Classification
- Class II
- Recalling firm
- Pfizer Inc.
- Product quantity
- 21,120 HDPE bottles
- Termination date
- May 8, 2017
- Reason for recall
- Subpotent Drug
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01
- Distribution pattern
- Nationwide
- Recall initiation date
- Sep 24, 2015
- Initial firm notification
- Letter
- Center classification date
- Oct 29, 2015